Back to TNGX
TCG Crossover Management, LLC → TNGX
TCG Crossover Management, LLC TNGX Position History
Tango Therapeutics, Inc.
Quarters held
4
Latest value
$169M
Q3 2026
Peak value
$283.9M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $113.1M |
| Q1 2026 | $220.3M |
| Q2 2026 | $283.9M |
| Q3 2026 | $169M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $169M | 6.77M | — | — |
| Q2 2026 | $283.9M | 9.08M | — | — |
| Q1 2026 | $220.3M | 10.53M | — | — |
| Q4 2025 | $113.1M | 12.76M | — | — |
Other funds holding TNGX
$434.5M
$350.5M
$301.6M
$279.2M
$278.2M
Other TCG Crossover Management, LLC positions
AAVXF
$959MABIVAX SA AMERICAN DEPOSITARY SHARES
AAVXF
$800.6MABIVAX SA AMERICAN DEPOSITARY SHARES
AAVXF
$721.7MABIVAX SA AMERICAN DEPOSITARY SHARES
AAVXF
$362.7MABIVAX SA AMERICAN DEPOSITARY SHARES
CGON
$260.8MCG ONCOLOGY INC
CGON
$260.2MCG ONCOLOGY INC
CGON
$248.4MCG ONCOLOGY INC
COGT
$208.4MCOGENT BIOSCIENCES INC